(PRESS RELEASE) STOCKHOLM, 29-Jul-2022 — /EuropaWire/ — Skanska (STO: SKA-B), a world leading project development and construction group, has announced its intention to reduce the total number of votes in the company by having Series A shares converted into Series … Read the full press release
(PRESSEMITTEILUNG) STOCKHOLM, 29-Jul-2022 — /EuropaWire/ — Skanska (STO: SKA-B), ein weltweit führendes Projektentwicklungs- und Bauunternehmen Group, hat ihre Absicht angekündigt, die Gesamtzahl der Stimmen in der Gesellschaft zu verringern, indem Aktien der Serie A in Aktien der Serie B umgewandelt … Read the full press release
Posted in Business, Construction, Financial, Industrial, Investment, Management, Sweden
Tagged Aktien, Aktien der Serie A, Aktien der Serie B, Aktionäre, Conversion of shares, schwedisches Gesetz über den Handel mit Finanzinstrumenten, Series A shares, Series B shares, shareholders, shares, Skanska AB, Swedish Financial Instruments Trading Act, Umwandlung von Aktien
Stockholm, 01-8-2013 — /EuropaWire/ — According to Husqvarna AB´s articles of association, owners of Class A shares have the right to have such shares converted to Class B shares. Conversion reduces the total number of votes in Husqvarna AB. When such a … Read the full press release
EuropaWire (EW) is the first truly pan-European and leading press release distribution and newswire service for Europe and the European Union working towards consolidating Europe’s voice on the global newswire and media scene. The newswire service comes with advanced submission forms, flexible pricing and PR budgeting, granular targeting, nearly uncapped reach across countries, markets, verticals, industries, audiences, languages, etc., translation and localisation for greater local PR impact, in-depth distribution reporting, metrics and insights including measured PR reach, reads, engagements, impact, etc., no cap on words, images and multimedia to go along with your release, among others. Your press releases will be seen among the releases of Europe’s biggest and most prominent companies, brands and institutions.
HOW TO GET STARTED?
PHARMA & BIOTECH: The largest repository of EU/European pharma & biotech press releases spanning 12 years (2012-2024)
